Skip to Main Content

Lou Hart, MD

Assistant Professor of Clinical Pediatrics (Hospital Medicine); Medical Director of Health Equity, Yale New Haven Health System



Louis Hart, MD is the inaugural Medical Director of Health Equity for Yale New Haven Health System (YNHHS). His mission in the Office of Health Equity (OHE) is to identify and eliminate unjust racial and social disparities that exist in our healthcare systems and manifest themselves as devastating healthcare inequities for the children, adults, families and communities that we are privileged to call our patients. This goal is part of a broader, collective effort to improve the health and wellbeing of all patients.

By proactively identifying and working to eliminate institutional bias, structural racial inequity, and social impediments to health, Dr. Hart envisions a system that is more just, adaptable, data-informed and accountable in sharing high-quality, safe and equitable care to every patient, every time. By calling everyone into this mission and acknowledging that there is no comfort in growth, in the end he believes we are always stronger and better as we grow together!

He is active clinically and continues to see and educate patients as a Pediatric Hospitalist, and is also responsible for teaching medical students and resident physicians as an Assistant Professor of Pediatrics and faculty member in the Yale School of Medicine.

Prior to joining the team at Yale, while the Director of Equity, Quality & Safety at NYC Health + Hospitals (NYC H+H), the nation's largest integrated municipal public healthcare system, Dr. Hart ingrained an equity lens into the Office of Quality & Safety, starting with the Quality Assurance / Performance Improvement (QAPI) infrastructure and the patient safety adverse event reporting/review systems. He also founded and led NYC H+H's Medical Eracism initiative that focuses on abolishing the use of race as biology in clinical tools and algorithms that further contribute to health and healthcare inequities. In NYC H+H's initial efforts, they were successful in eliminating race-based clinical adjustments in eGFR reporting, VBAC counseling, and Pediatric UTI risk assessment systemwide.

Education & Training

  • Clinical Leadership Fellow
    NYC Health + Hospitals (2020)
  • Residency
    NYU Grossman School of Medicine & NYC Health + Hospitals/Bellevue (2019)
  • MD
    University of California, San Diego, Doctor of Medicine (2016)
  • BA
    Vanderbilt University, Financial Economics / Medicine, Health & Society / Philosophy (2010)

Departments & Organizations